Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Barusiban (FE200440) in Preterm Labour
NCT00209326Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Nov 2003
- Primary completion
- Jul 2006
- Modality
- Peptides, Small Molecules
- Countries
- 6
01
Overview
Phase 2, randomised, double-blind trial of barusiban in Preterm labor (PTL) (5 arms), sponsored by Ferring Pharmaceuticals. Primary endpoint: Effect on stopping preterm labour. Started Nov 2003; status: completed.
02
Drugs
barusiban
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on NCT00209326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00209326.